Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bone Marrow Stromal Cells Reverse Proapoptotic Effects of JAK2 Inhibitor Atiprimod in Cells Carrying the JAK2 V617F mutation

Taghi Manshouri, Zeev Estrov, Jan Burger, Ana Livun, Ying Zhang, Shuhuang Ma, Amos Gaikwad, David Harris, Hagop M Kantarjian, Srdan Verstovsek

Blood (2008) 112 (11): 3738.

https://doi.org/10.1182/blood.V112.11.3738.3738

Published: 2008

Journal Articles

Role of JAK2 V617F during In Vitro PV Erythroid Progenitor Differentiation.

Roberto Nussenzveig, PhD, Amos Gaikwad, PhD, Taghi Manshouri, PhD, Karen Dwyer, PhD, Ying Zhang, Hagop Kantarjian, MD, Srdan Verstovsek, MD, PhD

Blood (2007) 110 (11): 2540.

https://doi.org/10.1182/blood.V110.11.2540.2540

Published: 2007

Journal Articles

Novel Mechanism of β0 Thalassemia: Missense Mutation of the Last Nucleotide of β Globin Exon 1 (G->C) Leads to Undetectable Transcript and Mutant Peptide.

Neeraj Agarwal, MD, Mariluz P. Mojica-Henshaw, MD, PhD, Ferdane Kutlar, MD, Amos Gaikwad, MD, Ching N. Ou, PhD, Abdullah Kutlar, MD, Josef T. Prchal, MD

Blood (2006) 108 (11): 1598.

https://doi.org/10.1182/blood.V108.11.1598.1598

Published: 2006

Journal Articles

Atiprimod Inhibits the Growth of JAK2 Tyrosine Kinase Over-Expressing Cells “In Vitro” and “Ex Vivo”.

Roberto Nussenzveig, PhD, Taghi Manshouri, PhD, Hagop Kantarjian, MD, Francis Giles, MD, Jorge Cortes, MD, Amos Gaikwad, PhD, Waldemar Priebe, PhD, Zeev Estrov, MD, Srdan Verstovsek, MD

Blood (2006) 108 (11): 4924.

https://doi.org/10.1182/blood.V108.11.4924.4924

Published: 2006

Journal Articles

In Vitro Expansion of Polycythemia Vera Progenitors Favors Expansion of Erythroid Precursors without JAK2 V617F Mutation.

Josef T. Prchal, MD, Ko-Tung Chang, PhD, Jaroslav Jelinek, MD, Yongli Guan, Amos Gaikwad, PhD, Jean-Pierre Issa, MD, Enli Liu, MD

Blood (2005) 106 (11): 3506.

https://doi.org/10.1182/blood.V106.11.3506.3506

Published: 2005

NARROW

Bone Marrow Stromal Cells Reverse Proapoptotic Effects of JAK2 Inhibitor Atiprimod in Cells Carrying the JAK2 V617F mutation

Role of JAK2 V617F during In Vitro PV Erythroid Progenitor Differentiation.

Novel Mechanism of β0 Thalassemia: Missense Mutation of the Last Nucleotide of β Globin Exon 1 (G->C) Leads to Undetectable Transcript and Mutant Peptide.

Atiprimod Inhibits the Growth of JAK2 Tyrosine Kinase Over-Expressing Cells “In Vitro” and “Ex Vivo”.

In Vitro Expansion of Polycythemia Vera Progenitors Favors Expansion of Erythroid Precursors without JAK2 V617F Mutation.

Email alerts

ASH Publications

American Society of Hematology

Bone Marrow Stromal Cells Reverse Proapoptotic Effects of JAK2 Inhibitor Atiprimod in Cells Carrying the JAK2 V617F mutation

Role of JAK2 V617F during In Vitro PV Erythroid Progenitor Differentiation.

Novel Mechanism of β0 Thalassemia: Missense Mutation of the Last Nucleotide of β Globin Exon 1 (G->C) Leads to Undetectable Transcript and Mutant Peptide.

Atiprimod Inhibits the Growth of JAK2 Tyrosine Kinase Over-Expressing Cells “In Vitro” and “Ex Vivo”.

In Vitro Expansion of Polycythemia Vera Progenitors Favors Expansion of Erythroid Precursors without JAK2 V617F Mutation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only